Researchers are exploring the use of synthetic gene circuits in tumor immunotherapy, with various approaches being developed to enhance cancer immune responses. These approaches include the use of single-cell encapsulation, gene circuit-engineered cells, and programmable living therapeutics, among others. The goal of these strategies is to improve the specificity and efficacy of cancer immunotherapy, with some methods also incorporating biomaterials and artificial intelligence to deceive the tumor microenvironment.